Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BCD-245 by Biocad for Neuroblastoma: Likelihood of Approval
BCD-245 is under clinical development by Biocad and currently in Phase I for Neuroblastoma. According to GlobalData, Phase I drugs...
BCD-245 by Biocad for Osteosarcoma: Likelihood of Approval
BCD-245 is under clinical development by Biocad and currently in Phase I for Osteosarcoma. According to GlobalData, Phase I drugs...
BCD-245 by Biocad for Ewing Sarcoma: Likelihood of Approval
BCD-245 is under clinical development by Biocad and currently in Phase I for Ewing Sarcoma. According to GlobalData, Phase I...
ANB-10 by Biocad for Hemophilia A (Factor VIII Deficiency): Likelihood of Approval
ANB-10 is under clinical development by Biocad and currently in Phase II for Hemophilia A (Factor VIII Deficiency). According to...
Bevacizumab biosimilar by Biocad for Non-Small Cell Lung Cancer: Likelihood of Approval
Bevacizumab biosimilar is under clinical development by Biocad and currently in Phase III for Non-Small Cell Lung Cancer. According to...
BCD-180 by Biocad for Ankylosing Spondylitis (Bekhterev's Disease): Likelihood of Approval
BCD-180 is under clinical development by Biocad and currently in Phase III for Ankylosing Spondylitis (Bekhterev's Disease). According to GlobalData,...
Pembrolizumab biosimilar by Biocad for Solid Tumor: Likelihood of Approval
Pembrolizumab biosimilar is under clinical development by Biocad and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Pembrolizumab biosimilar by Biocad for Non-Small Cell Lung Cancer: Likelihood of Approval
Pembrolizumab biosimilar is under clinical development by Biocad and currently in Phase I for Non-Small Cell Lung Cancer. According to...
Divozilimab by Biocad for Neuromyelitis Optica (Devic's Syndrome): Likelihood of Approval
Divozilimab is under clinical development by Biocad and currently in Phase III for Neuromyelitis Optica (Devic's Syndrome). According to GlobalData,...